$2.1 Billion Boost for AI Drug Discovery
In brief
- Isomorphic Labs, a leading AI-driven drug research company founded by DeepMind co-founder Demis Hassabis, has secured a significant investment of $2.1 billion in its Series B round led by Thrive Capital.
- This funding will be utilized to expand IsoDDE, the company's proprietary AI platform, and accelerate several drug candidates into clinical trials.
- This move underscores the growing confidence in AI's potential to revolutionize the pharmaceutical industry.
- By automating complex drug discovery processes, IsoDDE can analyze vast datasets and identify promising compounds more efficiently than traditional methods.
- The investment highlights the importance of scaling such technologies to address unmet medical needs and potentially bring life-saving treatments to market faster.
- With this new capital, Isomorphic Labs aims to expand its research capabilities and collaborate with leading biotech companies.
- Watch for updates on how AI-driven drug discovery continues to transform healthcare and deliver innovative therapies.
Terms in this brief
- IsoDDE
- IsoDDE is Isomorphic Labs' AI platform designed for drug discovery. It uses artificial intelligence to analyze large datasets and identify promising compounds more efficiently than traditional methods, potentially speeding up the development of life-saving treatments.
Read full story at The Decoder →
More briefs
AI Stock Sees Solid Revenue Growth
AI company ASML serves a key role in the artificial intelligence supply chain. It makes critical equipment used to make chips and is seeing solid revenue growth. ASML's revenue growth matters because it shows high demand for its products. The company's trailing 12-month revenue is up 76% since 2022. Over $2.5 trillion will be invested in AI infrastructure in the next few years. This investment will drive growth for ASML. With chip demand outpacing supply, the company is set for further growth in the future.
Nasdaq 100 Gains 140% Since ChatGPT Launch
The Nasdaq 100 has gained over 140% since the launch of OpenAI's ChatGPT. This gain is still lower than the index's 1,090% return at the dot-com bubble's peak in March 2000. The current AI bull market seems fairly reserved with valuations more grounded at 25 times forward earnings. Global AI spending is set to rise from $340 billion in 2025 to around $3 trillion in 2035 and AI's share of total tech spending will grow to 23%. AI spending will continue to increase in the future.
Meta AI Chief Defends Team
Meta's AI chief says his team is not motivated by money. He says top AI researchers joined Meta because they wanted to work with a lot of compute. Top AI researchers reportedly received $100 million offers to join Meta. But the AI chief says they were motivated by other factors. He says they wanted to make progress with a lot of compute and work with great talent. Meta spent $14 billion to acquire nearly half of Scale AI and to lure the AI chief to lead a new AI team. The company will continue to recruit top AI researchers to build its team.
China Faces AI Hardware Shortages Amid Soaring Demand
China's artificial intelligence hardware suppliers are struggling to meet surging demand due to critical component shortages and insufficient production capacity, according to Bloomberg. This scarcity has led to delays in delivering essential parts for AI systems, which are in high demand across various industries. The situation highlights the challenges faced by manufacturers in keeping up with the rapid growth of AI technology. The shortage of key components, such as chips and sensors, is a significant hurdle for China's AI sector. This issue not only affects hardware production but also impacts the development of advanced AI systems that rely on these components. The lack of supply has forced companies to slow down their production lines, creating a bottleneck in the industry. Looking ahead, experts suggest that this shortage may continue as global demand for AI hardware remains strong. China's ability to address these supply chain issues will be crucial for maintaining its position in the AI market.
AI Startup Recursive Emerges with $650 Million for Self-Improving Systems
AI startup Recursive has revealed itself from stealth, aiming to unlock superintelligence through self-improving systems. The company is betting on recursive self-improvement as the quickest route to achieving advanced AI capabilities, a strategy that could accelerate progress in machine learning. The firm has raised $650 million in funding, signaling confidence in its approach. While most AI models rely on fixed instructions from developers, Recursive's system enables AI agents to identify and correct their own errors without human intervention. This self-reinforcement loop allows for continuous improvement, potentially leading to more robust and adaptive AI systems. As the race for smarter AI intensifies, watch for how Recursive's technology evolves and whether it can scale its ambitious vision. The implications for future AI development are significant, with potential breakthroughs in areas like autonomous systems and problem-solving algorithms.